Physician profile
Alexa Littlejohn
NPI 1497130801
$1,275.82
in general payments reported to CMS, 2019-2025
19 companies · $348 in 2025
The $348 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $424 · 2023: $241 · 2024: $262 · 2025: $348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $772 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $771.55 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $223.15 | 2023-2025 | |
| Abbvie INC. | $141.46 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $128.41 | 2021-2025 | |
| Incyte Corporation | $95.32 | 2023-2025 | Opzelura |
| Galderma Laboratories, L.P. | $85.89 | 2021 | |
| Sanofi-Aventis U.S. LLC | $79.99 | 2025 | |
| Janssen Biotech, INC. | $74.12 | 2021-2025 | Tremfya |
| Pfizer INC. | $70.67 | 2021 | |
| Vyne Pharmaceuticals INC. | $68.91 | 2021 | |
| Almirall LLC | $60.95 | 2021-2023 | Seysara |
| Ucb, INC. | $40.42 | 2021-2024 | Bimzelx |
| E.R. Squibb & Sons, L.L.C. | $39.55 | 2024-2025 | Sotyktu |
| Dermavant Sciences, INC. | $33.70 | 2023-2024 | Vtama |
| Sun Pharmaceutical Industries INC. | $33.33 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $24.45 | 2024 | Arazlo |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $23.40 | 2025 | Vtama |
| Leo Pharma INC. | $19.17 | 2021 | |
| Amgen INC. | $17.34 | 2021 | |
| Sebela Pharmaceuticals INC. | $15.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexa Littlejohn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.